Literature DB >> 8589765

Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice.

T Yoshida1, N Sakane, Y Wakabayashi, T Umekawa, M Kondo.   

Abstract

OBJECTIVE: To investigate the hypothesis that anti-obesity action of bofu-tsusho-san (TJ-62) works via activating the brown adipose tissue thermogenesis and inhibiting the phosphodiesterase activity.
DESIGN: MSG obese mice and lean controls were fed a diet including 1.4% or 4.7% TJ-62 of weight of food for 8 weeks. Another group of MSG obese mice were fed with 1-ephedrine (1-E) + d-pseudoephedrine (d-PE) of equivalent amounts as contained in TJ-62 (4.7%) for 8 weeks. Yet another group of MSG obese mice were further supplemented with Glycyrrhizae Radix (GR) extract + Forsythiae Fructus (FF) extract + Schizonepetae Spica (SS) extract (that inhibited phosphodiesterase activity) of amounts contained in TJ-62 (4.7%) for 8 weeks. MEASUREMENTS: The following were measured: The concentration of ephedrine and its congeners in TJ-62; the inhibitory effect of TJ-62 on phosphodiesterase activity; body weight; food intake; retroperitoneal white adipose tissue (RWAT) weight; interscapular brown adipose tissue (IBAT) weight; mitochondrial protein content in IBAT; cytochrome c oxidase activity in IBAT; guanosine-5'-diphosphate (GDP) binding in IBAT mitochondria.
RESULTS: One gram of TJ-62 contained 3.33 mg of 1-E and 0.73 mg of d-PE. One mg of TJ-62 was equivalent to 2.5 mg of caffeine in the inhibitory effect on phosphodiesterase activity. After feeding with TJ-62, GDP binding was significantly increased in a dose dependent manner. Body weight and RWAT weight decreased in both MSG obese mice and lean controls. Food intake was not changed by TJ-62. Feeding with 1-E + d-PE produced responses of about 70% of those of TJ-62. These responses were, furthermore, enhanced by the addition of the three extracts to the levels that were similar to those produced by TJ-62.
CONCLUSION: Bofu-tsusho-san (TJ-62) works via activating the BAT thermogenesis and inhibiting the phosphodiesterase activity in mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589765

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  14 in total

1.  Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.

Authors:  Weibin Qian; Junichi Hasegawa; Satoshi Tsuno; Yusuke Endo; Akiko Matsuda; Norimasa Miura
Journal:  Yonago Acta Med       Date:  2014-12-26       Impact factor: 1.641

2.  Investigation on the absorption of phillyrin and forsythiaside in rat digestive tract.

Authors:  Yun-xia Li; Cheng Peng; Liang-hong Ye; Ruo-Qi Zhang; Xue-hua Jiang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-03-09       Impact factor: 2.441

3.  A case study of bofutsushosan-induced pulmonary injury in a patient: Case report.

Authors:  Kunihiko Miyazaki; Hiroaki Satoh; Hiroko Watanabe; Toshihiro Shiozawa; Tomohiro Tamura; Mio Kawaguchi; Nobuyuki Hizawa
Journal:  Biomed Rep       Date:  2016-10-19

Review 4.  A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity.

Authors:  Shirin Hasani-Ranjbar; Neda Nayebi; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

5.  Pharmacokinetics of phillyrin and forsythiaside following iv administration to Beagle dog.

Authors:  Yun-Xia Li; Cheng Peng; Ruo-Qi Zhang; Xue Li; Xue-Hua Jiang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Apr-Jun       Impact factor: 2.441

6.  Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence.

Authors:  Jun-Ichi Yamakawa; Junji Moriya; Kenji Takeuchi; Mio Nakatou; Yoshiharu Motoo; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

7.  Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.

Authors:  Cheng-Hsiu Lin; Yueh-Hsiung Kuo; Chun-Ching Shih
Journal:  Int J Mol Sci       Date:  2014-11-04       Impact factor: 5.923

8.  A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats.

Authors:  Jun-Ichi Yamakawa; Junji Moriya; Takashi Takahashi; Atsushi Ishige; Yoshiharu Motoo; Fumihiko Yoshizaki; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2007-11-14       Impact factor: 2.629

9.  Bofutsushosan, an Oriental Herbal Medicine, Attenuates the Weight Gain of White Adipose Tissue and the Increased Size of Adipocytes Associated with the Increase in Their Expression of Uncoupling Protein 1 in High-Fat Diet-Fed Male KK/Ta mice.

Authors:  Satomi Akagiri; Yuji Naito; Hiroshi Ichikawa; Katsura Mizushima; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Toshikazu Yoshikawa
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

10.  Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity.

Authors:  Kengo Azushima; Kouichi Tamura; Hiromichi Wakui; Akinobu Maeda; Masato Ohsawa; Kazushi Uneda; Ryu Kobayashi; Tomohiko Kanaoka; Toru Dejima; Tetsuya Fujikawa; Akio Yamashita; Yoshiyuki Toya; Satoshi Umemura
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.